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ABSTRACT 
 
 
Background: Massachusetts’ 2006 health reform has been called a model for the Affordable 
Care Act.  The law attained near-universal insurance coverage and increased access to care.  Its 
impact on population health is less clear. 
 
Objective: To determine whether Massachusetts’ reform was associated with changes in all-
cause mortality and mortality from causes amenable to health care. 
 
Design: Comparison of mortality rates before and after reform in Massachusetts versus a control 
group with similar population demographics and economic conditions.   
 
Setting: Massachusetts’ reform created a natural experiment on health insurance expansion.  We 
compared changes in mortality rates for adults in Massachusetts counties from 2001-2005 (pre-
reform) to 2007-2010 (post-reform), versus changes in a propensity-score defined control group 
of counties in other states.  
 
Participants: Adults ages 20-64 in Massachusetts and control counties.   
 
Outcome Measures: Annual county-level all-cause mortality in sex-age-race specific cells 
(cells: n=146,825) from the CDC’s Compressed Mortality File.  Secondary outcomes were 
deaths from causes amenable to health care; insurance coverage; access to care; and self-reported 
health.  
 
Results: Massachusetts’ reform was associated with a significant decline in all-cause mortality 
compared to the control group (-2.9 percent, p=0.003, or an absolute decline of 8.2 deaths per 
100,000).  Deaths from causes amenable to health care also significantly declined (-4.5 percent, 
p<0.001).  Changes were larger in counties with lower household incomes and higher pre-reform 
uninsured rates. Secondary analyses showed significant gains in coverage, access to care, and 
self-reported health.  The number-needed-to-treat was approximately 830 people gaining health 
insurance to prevent one death per year. 
 
Limitations: Non-randomized design subject to unmeasured confounders; Massachusetts may 
not generalize to other states. 
 
Conclusions: Massachusetts’ reform was associated with significant declines in all-cause 
mortality and deaths from causes amenable to health care. 
 
Primary Funding Source: None. 
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INTRODUCTION 
 Massachusetts passed comprehensive health reform in 2006 with the goal of near-
universal coverage.  The law – which expanded Medicaid, offered subsidized private insurance, 
and created an individual mandate – was a model for the Affordable Care Act (ACA).1  Thus, 
understanding the Massachusetts law’s impact has important policy implications. 
 Previous research documents that Massachusetts’ reform succeeded in expanding health 
insurance among adults ages 19 to 64 by 3-8 percentage points.1-5  Studies also indicate 
improvements in access to care,6-8 self-reported physical and mental health,9 use of preventive 
services,2,10 and functional status.1,11  However, there has been no evidence on the law’s effect on 
mortality.  Previous research of health insurance’s impact on mortality is mixed.  Some 
observational studies suggest as much as a 40% higher risk of death for uninsured versus insured 
adults,12,13 and one analysis of Medicaid expansions to low-income adults detected a 6% decline 
in statewide mortality.14  Other studies – including two randomized trials of insurance expansion 
– found little or no mortality impact.15-17 
 This study’s objective was to examine the changes in mortality associated with 
Massachusetts’ reform.  We hypothesized that the reform reduced mortality, particularly from 
causes potentially treatable with timely care (such as cardiovascular disease, infections, and 
cancer), and that larger changes occurred among groups likely to benefit from the law – 
previously uninsured adults and those with higher baseline mortality.   
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METHODS 
Study Design  
 Our study used a quasi-experimental pre-post design with a control group, comparing 
average mortality in Massachusetts before and after reform to mortality changes over the same 
period for similar populations in states without reforms (also known as a “differences-in-
differences” analysis18).  Our preferred specification employed propensity-score methods to 
create a control group of counties in non-reform states that best matched the distribution of pre-
reform characteristics in Massachusetts counties.19,20   
The Massachusetts law had several components: a Medicaid expansion starting in July 
2006 for adults; subsidized private plans for adults under 100% of the federal poverty level 
(FPL) in October 2006; and expanded coverage subsidies for adults up to 300% of FPL in 
January 2007.  It included an individual mandate effective for the 2007 tax year, as well as 
“minimum creditable coverage” insurance standards.21  We defined the post-reform period as 
2007-2010, with 2006 omitted as a transitional year (though we included 2006 in sensitivity 
analyses).   Our pre-reform period was 2001-2005. 
  
Data 
Our data came primarily from the Centers for Disease Control and Prevention (CDC)’s 
Compressed Mortality File, which provides county-specific annual mortality rates stratified by 
age, sex, and race.22  For confidentiality, the publicly-available dataset suppresses death counts 
for cells with fewer than 10 deaths; we obtained access to the non-suppressed dataset under 
agreement with the CDC.  Our sample contained adults ages 20-64, the group most directly 
targeted by the reform (with 19 year-olds excluded because 15-19 year-olds are grouped together 
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in the dataset).  In addition to age, sex, and race, our estimates adjusted for year-specific county-
level poverty rates, median income, unemployment, and Latino percentage of the population, all 
from the Area Resource File (ARF).23  Subgroup analyses used pre-reform county-level 
uninsured rates from the Census Bureau’s 2005 Small Area Health Insurance Estimates.24   
We also analyzed measures of coverage, health care access, and self-reported health 
status from two nationally-representative household surveys: CDC’s Behavioral Risk Factor 
Surveillance System (BRFSS) and the Census Bureau’s Current Population Survey (CPS).  
These datasets have been used previously to examine the impact of the Massachusetts reform on 
coverage and access;2-4,8,9,25 we present independent estimates using methods analogous to our 
mortality analysis to provide additional context for our results.  For these data sources, we were 
able to include 19 year-olds, so the sample contains all non-elderly adults 19-64. 
This project used pre-existing deidentified data and was deemed exempt from review by 
the Harvard Institutional Review Board.  The project received no external funding. 
 
Outcome Measures 
Our primary outcome was all-cause mortality.  Our secondary outcome was mortality 
amenable to health care, adapted from previous research, to focus on deaths related to conditions 
that are more likely to be preventable or treatable with timely care,26-29 including deaths due to 
heart disease, stroke, cancer, infections and other conditions.30 Appendix Table 1 lists the ICD-
10 codes in this definition and a more restrictive alternate definition tested in a sensitivity 
analysis.   
Additional outcomes were health insurance from the CPS, and self-reported health 
(excellent/very good versus good/fair/poor) and access-to-care measures (cost-related delays in 
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care, lacking a usual source of care, and absence of a preventive visit in the past year) from the 
BRFSS.  
 
Analysis 
Annual age-sex-race-specific county-level death counts were the unit of observation for 
the mortality analysis.  Table 1 describes the analytic sample, which contains information on the 
number of counties, states, age-sex-race-specific county-level cells, and population per year. 
Our regression models estimated the average annual pre-post change in mortality for age-
sex-race-specific cells in Massachusetts counties relative to comparison counties in non-reform 
states.  Given that our dataset presents deaths as count data within each cell, multivariate 
regression analyses fitted a generalized linear model (GLM), using a negative binomial 
distribution and log-link, with cell population as the exposure variable.  Analyses adjusted for 
race, sex, age, state, year, and county-year-specific economic factors listed above (see Appendix 
for details).  
Our study contained five years of pre-reform data (2001-2005) and four years of post-
reform data (2007-2010), and our model estimated the change in level of mortality pre- versus 
post-reform.31  Robust standard errors were clustered at the state level to account for serial 
autocorrelation and for the state-level nature of the policy intervention,18 as is standard in 
population-based policy analyses.14,32-37  Sensitivity analyses included pooling annual data into 
pre-reform and post-reform periods to remove potential autocorrelation, an interrupted time-
series model, adding 2006 (the implementation year) to our post-reform data, and county-level 
clustering of standard errors.  We also tested a linear model using death rate per 100,000 adults 
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as the outcome, to provide simple estimates of absolute change and results comparable to prior 
research.14  Cells were weighted by population size to yield population-representative estimates.  
Secondary analyses used individual-level information from the BRFSS and CPS on 
coverage, access, and health status, and adjusted for age, sex, race/ethnicity, employment, 
household income, year, and state.  For these binary outcomes, we used a generalized linear 
model with a logit link, with predicted probabilities used to describe the magnitude of absolute 
changes.38 
 
Selection of Control Group 
For the mortality analysis, we used propensity scores to define a control group of 
counties in non-reform states that were most similar to Massachusetts counties prior to reform. 
We estimated propensity scores with a population-weighted logistic regression model using age 
distribution, sex, race/ethnicity, poverty rate, median income, unemployment, uninsured rate, and 
baseline annual mortality as predictors (Appendix Table 2).  The quartile of counties with the 
highest propensity scores – indicating the closest match to the overall population of 
Massachusetts’ 14 counties – were used as the control group in the mortality analysis.  This 
approach yielded excellent balance on key features between Massachusetts and our control group 
(Table 2) and provided adequate sample sizes for subgroup analyses.  We also tested a more 
traditional propensity score regression adjustment method and a 2:1 nearest-neighbor propensity 
score matching approach, which yielded similar overall results (see Appendix for details).   
Identifying a control group with similar trends in mortality absent Massachusetts’ reform 
is the key to our approach.20  We tested for differences in the pre-reform mortality trends for 
2001-2006 between Massachusetts and the control group, using both linear and quadratic time 
 7 
trends interacted with an indicator variable for Massachusetts.  We repeated this test for the full 
U.S. population.  
For the analysis of coverage, access, and self-reported health in the CPS and BRFSS, we 
compared Massachusetts to other New England states (Maine, Vermont, New Hampshire, Rhode 
Island, and Connecticut) before and after reform.  These datasets do not contain the county-level 
detail needed for our propensity score method, so we follow previous research in using this 
control group.2,3,11 
 
Subgroup Analyses 
 We conducted pre-specified subgroup analyses to test for heterogeneous mortality 
changes and impact on disparities.  We examined 20-34 versus 35-64 year-olds; white non-
Latinos versus non-whites and Latinos; residents of low- versus high-income counties (based on 
Massachusetts’ median household income); and residents of counties with low versus high adult 
uninsured rates (based on Massachusetts’ pre-reform median county uninsured rates).  In each 
analysis, we specified an interaction term between Massachusetts’ reform and the variable in 
question, to test whether there were significantly different impacts across subgroups. 
Finally, we used elderly adults (65 and older) as an additional control group.  This 
approach subtracts out any secular trend for elderly adults in Massachusetts from the estimated 
mortality change for non-elderly adults (see Appendix for details).  Netting out the mortality 
changes in this group is a conservative approach: while Massachusetts’ reform did not directly 
affect coverage for most elderly adults, it did expand insurance to the few who do not meet 
lifetime earnings requirement for Medicare.2,39  It may thus have had some impact on health in 
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this age group, but one would expect such effects to be much weaker than the impact on the 
targeted population of non-elderly adults. 
  
RESULTS 
Sample 
 Table 2 presents descriptive statistics and baseline mortality for counties in 
Massachusetts, our control group, and all U.S. counties outside Massachusetts.  Massachusetts 
had significantly fewer minorities, more women, lower poverty and uninsured rates, and lower 
baseline mortality than the rest of the U.S.  However, there were no statistically significant 
differences for these outcomes between Massachusetts and the control group, indicating 
excellent balance from the propensity score approach.  
 Examination of pre-reform mortality trends further supports the use of control group 
(Appendix Table 3).  We found no evidence of divergence between Massachusetts and the 
control group in either linear or quadratic models (p>0.10).  In contrast, Massachusetts’ mortality 
trend diverged from the rest of the U.S. before 2006 (p<0.001). 
 
Changes in Mortality 
Figure 1 shows unadjusted annual mortality for non-elderly adults in Massachusetts and 
the control group from 2001-2010.  All-cause mortality in the two groups followed a similar 
pattern until the reform law’s implementation in 2006-2007, after which mortality in 
Massachusetts began to decline relative to the control group.  Health-care amenable mortality 
followed a similar pattern, while trends for other causes of death showed minimal changes within 
Massachusetts and the control group.  
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 Table 3 presents regression estimates for changes in mortality associated with 
Massachusetts’ reform.  In our primary specification, adjusted all-cause mortality declined in 
Massachusetts after reform by 2.9% (p=0.003), compared to the control group.  Mortality 
amenable to health care declined by 4.5% (p<0.001).  An alternate definition of health-care 
amenable mortality28 produced a slightly larger relative reduction (-5.5%, p=0.002), and deaths 
from non-amenable causes showed no significant decline (-2.0%, p=0.26) (Appendix Table 1).   
 Numerous sensitivity analyses – including using propensity-score regression adjustment 
or 2:1 matching approaches, county-level clustered standard errors, or a linear model with the 
death rate as the outcome – produced similar results (Appendix Table 4).   The relative decline of 
2.9% in all-cause mortality, paired with baseline mortality in Massachusetts of 283 per 100,000, 
implies an absolute mortality reduction of -8.2 per 100,000, similar to the linear model estimate 
of -9.3 per 100,000 (p=0.014) reported in the Appendix.  
 
Mortality Changes Among Subgroups 
 Table 4 presents subgroup analyses.  Relative mortality reductions in Massachusetts 
compared to the control group were significant for whites and non-whites, 20-34 and 35-64 year-
olds, and residents of counties with lower incomes and higher baseline uninsured rates.  While 
relative mortality changes were larger for Latinos and non-whites (-4.6%, p<0.001) than for 
whites (-2.4%, p=0.001), the between-group difference in these estimates was not significant 
(p=0.062).   
 Appendix Figure 1 shows unadjusted mortality trends for elderly adults, with no apparent 
divergence between Massachusetts and the control group before or after reform.  A model using 
elderly adults as an additional within-state control group (Appendix Table 5) showed a -3.3% 
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change in all-cause mortality (p=0.066) for non-elderly adults and +0.1% for elderly adults 
(p=0.93) in Massachusetts after reform, and a -4.9% change in health-care amenable mortality 
(p<0.001) for non-elderly adults and a +0.2% change for elderly adults (p=0.90).   
 
Coverage, Access to Care, and Health 
 Table 5 shows changes in coverage, access to care, and self-reported health.  Compared 
to other New England states, Massachusetts’ reform was associated with significant reductions in 
the uninsured rate (-6.8 percentage-point change in predicted probability, a 57% relative decline 
from baseline), cost-related delays in care (-2.0 percentage points, 22% relative decline), lacking 
a usual source of care (-1.9 percentage points, 13% relative decline), having no preventive visit 
in the last year (-4.0 percentage points, 13% relative decline), and reporting good, fair or poor 
health (-1.8 percentage points, 5% relative decline), all changes p<0.01.  Results were nearly 
identical with linear probability models or without state-clustering of standard errors (Appendix 
Table 6). 
 
Estimated Mortality Effect 
To assess the plausibility of our estimated mortality decline, we compared it with the 
coverage gains we detected (Appendix Table 7).  In absolute terms, we found a 0.082 
percentage-point decline in mortality (8.2 per 100,000) in the setting of a 6.8 percentage-point 
coverage gain, which implies that for approximately every 830 individuals who gained 
insurance, there was one fewer death per year.  
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DISCUSSION 
Massachusetts’ 2006 health reform was associated with significant declines in all-cause 
mortality over 4 years of follow-up, relative to a control group of similar counties in states 
without reform.  Declines were concentrated in causes of death more likely amenable to health 
care and in populations most likely to benefit from expanded access, particularly residents of 
counties with lower incomes and higher pre-reform uninsured rates.  
Compared to the control group, overall mortality in Massachusetts declined by 2.9%.  
This relative decline in mortality is smaller than the 6.1% mortality decline associated with 
several states’ Medicaid expansions,14 consistent with the fact that Massachusetts began its 
expansion from a much higher baseline rate of insurance coverage.  However, two recent 
experimental studies of insurance have not shown a mortality benefit of insurance,16,17 nor 
statistically significant changes in blood pressure or glycated hemoglobin,40 though both found 
major gains in self-reported health and access to recommended care.  The latter studies have the 
advantages of a randomized design and individual-level data, but involve much smaller sample 
sizes (e.g. 916 gaining coverage in one study,17 roughly 10,000 newly-insured in another,40 
versus approximately 270,000 adults gaining coverage in our study) and shorter follow-up16,40 
than is possible using state-wide population data, giving our study far greater statistical power 
for small absolute changes such as those detected here.   
How does insurance expansion reduce population mortality? Our secondary outcomes 
trace out a plausible causal pathway: eligibility leads to increased coverage, coverage leads to 
better access and more utilization of clinical services including office visits, with resulting gains 
in self-reported health status (a strong predictor of mortality41,42).  This potential pathway of 
coverage leading to health gains via access to clinicians and high-quality care is consistent with 
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Eisenberg and Power’s seminal 2000 paper, which outlines a framework for understanding 
challenges to improving care for patients within the U.S. health care system.43   
Our results are consistent with the bulk of previous research on Massachusetts’ reform, 
demonstrating gains in coverage, access to care, and self-reported health among Massachusetts 
residents post-reform.1,2,8,10,11  Mortality reductions were concentrated in those conditions most 
likely amenable to health care, such as cancer (which can sometimes be prevented with earlier 
screening and/or treated more successfully with early detection), infections (treatable with early 
detection, and preventable or less likely to be fatal with better chronic disease management), and 
cardiovascular disease (treatable acutely with early detection, and partially preventable with risk 
factor modification).  This is consistent with research demonstrating a decline in potentially 
avoidable hospitalizations after Massachusetts’ reform2 and other insurance expansions.44 While 
research on breast cancer did not find a significant effect of Massachusetts’ reform,25 our use of a 
more comprehensive health outcome may have given us greater power to detect changes than 
analysis of a single diagnosis.  
Our “number needed to treat” was 830 adults gaining insurance to prevent one death per 
year.  This estimated coverage-to-mortality effect would be consistent with a 30% relative 
reduction in individual-level mortality for those gaining insurance (compared to an estimated 
25% relative reduction in mortality from insurance cited by the Institute of Medicine,13 and the 
40% relative reduction found by Wilper et al.12), if overall baseline mortality for these uninsured 
individuals were 400 per 100,000 (Appendix Table 7).  This baseline mortality rate would be 
roughly 1.5 times that of our overall sample, consistent with prior research on elevated mortality 
risks for the uninsured.12,15 In addition, research suggests that insurance expansions 
disproportionately enroll individuals in worse health,14,45 and components of the Massachusetts 
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expansion preferentially targeted adults with disabilities or HIV/AIDS.21  These illustrative 
calculations assume that mortality reductions occurred only for those obtaining insurance under 
reform, which may be conservative, since the law also expanded benefits (including preventive 
care and prescription drugs) for many who already had insurance. 
Reductions in mortality were largest in Massachusetts counties with lower incomes and 
lower pre-reform insurance coverage – areas likely to have experienced the greatest increase in 
access to care under reform.  Mortality reductions were nearly twice as large for minorities as for 
whites, though this between-group difference was not statistically significant.  These results 
provide useful additional information compared to previous research suggesting that racial/ethnic 
disparities in coverage and access may not have narrowed after Massachusetts’ reform.3,4 
Our analysis has several limitations.  First, we do not have individual-level insurance 
information and thus cannot directly link mortality changes to those gaining insurance coverage.  
Second, defining mortality from causes “amenable to health care” is somewhat subjective.  We 
built on methods used in prior research27-29 and tested two definitions that provided similar 
results.  Future research distinguishing between treatable and curable conditions would also be 
worthwhile.  
Most importantly, our quasi-experimental approach cannot definitively demonstrate a 
causal relationship underlying the association between Massachusetts’ reform and the state’s 
declining mortality relative to other states.  It is possible that the post-reform reduction in 
mortality in Massachusetts was due to other factors that differentially affected Massachusetts, 
such as the recession.  However, our analysis controlled for several distinct time- and county-
specific economic measures.  We also found no evidence of a similar decline in mortality among 
elderly adults in Massachusetts that would suggest a secular trend.  While we cannot rule out 
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unmeasured confounders, it is challenging to identify factors other than health reform that might 
have produced this pattern of results: a declining mortality rate in Massachusetts since 2007 not 
present in similar counties elsewhere in the country, primarily for health-care amenable causes in 
adults ages 20-64 (but not elderly adults), concentrated among poor and uninsured areas, and not 
explained by changes in poverty or unemployment rates. 
In conclusion, we find a significant reduction in mortality among non-elderly adults in 
Massachusetts since its 2006 reform, relative to a control group of similar counties in states 
without such reforms.  Though this analysis is unable to demonstrate causality, the results offer 
suggestive evidence that the ACA – modeled after the Massachusetts law – may impact not only 
coverage and access, but also mortality.  However, it is critical to note the many dimensions 
along which Massachusetts differs from the rest of the nation, with lower mortality, higher 
income and baseline insurance coverage rates, fewer minorities, and the most physicians per 
capita in the country.46  The extent to which our results generalize to the U.S. as a whole is 
therefore unclear, underscoring the need to monitor closely across all states the ACA’s impact on 
coverage, access, and population health.  
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Table 1: Analytic Sample 
 
Variable Value 
Counties  
   Massachusetts Counties 14 
   Control Group Counties 513 
   United States (non-Massachusetts) 3127 
      
States (including District of Columbia)     
   Massachusetts 1 
   Control Group States 46 
   United States (non-Massachusetts) 50 
  
County-Specific Age-Sex-Race Cells  
   Massachusetts Cells 3,985 
   Control Group Cells 142,840 
   United States (non-Massachusetts) 836,413 
  
Population Per Year, Ages 20-64  
   Massachusetts 3,900,000 
   Control Group 44,300,000 
   United States (non-Massachusetts) 173,400,000 
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Table 2:  Summary Statistics for Study Sample, Pre-Reform Period 
County-Level Characteristic Massachusetts Control Group 
P value, 
Massachusetts 
vs. Control 
Group 
Rest of 
United 
States 
P value, 
Massachusetts 
vs. Rest of 
United States 
Covariates      
Age 20-34 33.2% 33.1% 0.95 34.5% 0.46 
Age 35-44 26.3% 25.9% 0.51 25.3% 0.090 
Age 45-54 24.0% 24.3% 0.69 23.7% 0.68 
Age 55-64 16.5% 16.7% 0.79 16.4% 0.95 
Male 48.9% 49.1% 0.13 49.6% <0.001 
White 87.4% 85.0% 0.28 81.0% 0.003 
Black 7.0% 9.0% 0.26 12.8% <0.001 
Other Race 5.6% 6.0% 0.62 6.2% 0.46 
Latino Ethnicity 7.6% 7.9% 0.86 14.0% <0.001 
Poverty Rate 9.6% 10.2% 0.55 12.7% 0.002 
Median Household Income† $62,271 $59,124 0.30 $52,481 0.001 
Unemployment Rate 5.0% 5.1% 0.62 5.4% 0.058 
Uninsured Rate 13.6% 14.5% 0.18 19.8% <0.001 
      
Outcomes      
All-Cause Mortality (deaths per 
100,000) 283 297 0.26 341 <0.001 
Mortality Amenable to Health 
Care (deaths per 100,000)  185 197 0.11 221 <0.001 
 
Notes:  
† Median income was inflation-adjusted to 2010 dollars.  
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Table 3: Mortality Before and After Massachusetts’ Health Reform Among Adults 20-64 
(2001-2010) 
 
 
 
OUTCOME 
Unadjusted 
Mortality, per 
100,000 
Unadjusted Relative Change 
(percent) 
Adjusted Relative Change  
(percent) 
 Pre-Reform 
Post-
Reform  
Difference in 
Change, 
Massachusetts 
vs. Control 
Group 
95% CI P value 
Difference in 
Change, 
Massachusetts 
vs. Control 
Group 
95% CI P value 
All-Cause 
Mortality         
Massachusetts 283 274 
-4.2 -8.0, -0.4 0.032 -2.9 -4.8, -1.0 0.003 
Control Group 297 299 
         
Health Care 
Amenable 
Mortality 
        
Massachusetts 185 175 
-4.3 -7.2, -1.5 0.003 -4.5 -6.2, -2.7 <0.001 
Control Group 197 195 
 
Notes: Relative changes estimated using negative binomial generalized linear models with log-link.  Adjusted model 
controlled for population age, sex, race, and ethnicity distribution, poverty rate, median income, unemployment rate, 
and state of residence. 
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Table 4: Subgroup Analyses of All-Cause Mortality Changes After Massachusetts’ Health 
Reform Among Adults 20-64 (2001-2010) 
 
SUBGROUP 
Unadjusted 
Mortality in 
Massachusetts 
Prior to 
Reform, per 
100,000  
Adjusted 
Relative 
Change, 
Massachusetts 
vs. Control 
Group  
(percent) 
95% CI 
P value 
for 
subgroup 
P value 
for 
between-
group 
difference 
 Absolute 
Change in 
Predicted 
Mortality, 
per 100,000 
Full Sample 283 -2.9 -4.8, -1.0 0.003 -- -8.2 
White Non-
Latino§ 295 -2.4 -3.8, -1.0 0.001 0.062 
-7.1 
Latino or Non-
White§ 231 -4.6 -6.3, -2.8 <0.001 -10.6 
Ages 20-34 77 -3.6 -6.9, -0.4 0.030 0.38 -2.8 Ages 35-64 386 -2.2 -3.8, -0.6 0.008 -8.5 
Low-Income 
County 312 -3.0 -4.6, -1.3 <0.001 0.33 
-9.4 
High-Income 
County 257 -1.8 -4.0, 0.5 0.120 -4.6 
Low-Uninsured 
County 295 -1.7 -3.8, 0.4 0.118 0.41 
-5.0 
High-Uninsured 
County 273 -3.3 -6.0, -0.6 0.015 -9.0 
 
Notes: Relative changes estimated using negative binomial generalized linear models with log-link.  Adjusted model 
controlled for population age, sex, race, and ethnicity distribution, poverty rate, median income, unemployment rate, 
and state of residence.  Absolute change calculated using estimated relative change multiplied by baseline subgroup-
specific mortality for Massachusetts. 
§ While unadjusted mortality is higher for White Non-Latinos than for Latinos or Non-Whites, this is primarily due 
to the different age distributions of the groups.  After adjustment for age by standardizing to the white age 
distribution, baseline mortality for Latinos or Non-Whites is significantly higher (312/100,000) than mortality for 
White Non-Latinos (295/100,000).  This model omits from the sample any deaths with “unknown” ethnicity, since 
the dataset has no corresponding population denominator for that group necessary to calculate a death rate. 
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Table 5: Changes in Coverage, Access to Care, and Self-Reported Health After 
Massachusetts’ Health Reform Among Adults 19-64 (2001-2010) 
 
 
 
OUTCOME 
 Unadjusted 
Population Mean 
in Massachusetts 
Pre-Reform 
(percent)  
Adjusted Odds 
Ratio, Post-
Massachusetts 
Health Reform 
95% CI P value 
Absolute 
Change in 
Predicted 
Probability 
(percentage 
points) 
N 
Uninsured 11.9 0.43 0.41, 0.45 <0.001 -6.8 99,661 
Delayed Care Due 
to Cost in Past 
Year 
9.0 0.78 0.70, 0.86 <0.001 -2.0 215,365 
No Usual Source 
of Care 14.7 0.84 0.78, 0.89 <0.001 -1.9 262,761 
No Preventive 
Doctor’s Visit in 
Past Year 
30.5 0.82 0.79, 0.85 <0.001 -4.0 166,642 
Good/Fair/Poor 
Self-Reported 
Health (versus 
Excellent/Very 
Good) 
34.7 0.92 0.88, 0.95 <0.001 -1.8 214,510 
 
 
Notes: All analyses compare pre-post changes in the outcomes for Massachusetts versus other New England states, 
for the years 2001-2005 versus 2007-2010.  Data are from the Current Population Survey (CPS) for uninsured, and 
from the Behavioral Risk Factor and Surveillance System (BRFSS) for the remaining measures.  Sample sizes for 
BRFSS items differ primarily due to changes in which years of the survey each item was asked and small 
differences in item non-response. Adjusted model controls for age, sex, race, ethnicity/household income (as 
percentage of the federal poverty level), employment status, year, and state of residence.  Absolute change 
calculated using change in predicted probabilities.  
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Figure 1: Unadjusted Mortality Rates for Adults (20-64) from 2001-2010,  
in Massachusetts versus Control Group 
 
 
 
 
 
Notes:    
Gray band designates the beginning of the Massachusetts state health reform, implemented starting in July 2006. 
“Healthcare Amenable Mortality” is as defined in Appendix Table 1, with “other causes” containing all other causes 
of death not included in that definition. 
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Details of the Mortality Data Source and Sample Size 
The Compressed Mortality File is a county-level database containing information on all 
U.S. deaths in the prior year, and information on the county-specific population by various 
demographic features.  The database is collected and made publicly available by the National 
Center for Health Statistics at the Centers for Disease Control and Prevention (CDC), at the 
following website: http://wonder.cdc.gov/mortSQL.html.1 However, the publicly-available 
version suppresses death counts less than 10, so we obtained access under a data-use agreement 
with the CDC to the full non-suppressed dataset, which we used for our mortality analyses.2 
 Mortality information was obtained directly from death certificates.  Population 
information came from the U.S. Census Bureau, providing information on each county’s 
population by sex, age, ethnicity, and race.  Year-specific county-level poverty rates, median 
income, unemployment, and Latino percentage of the population all came from the Area 
Resource File (ARF).3 Data from 2010 economic measures were not available in the most recent 
ARF release at the time of this analysis, so we carried forward 2009 values; our results were 
essentially unchanged when we excluded 2010 data. 
 In our baseline analysis, our sample size was defined by the following equation: 
  N = # counties * 9 years * 2 sexes * 4 age groups * 4 races 
For Massachusetts, this yielded a possible 4032 county-level observations (for 14 
counties); however, 47 of these combinations had 0 population members, meaning there was no 
one of that age-race-sex combination in a county in a particular year.  The overall sample for 
Massachusetts in our analysis was therefore N=3,985 observations.   
We did not include Latino ethnicity as a stratification variable in our primary analysis, 
since ethnicity data are unknown for a portion of deaths in the mortality dataset and lack a 
corresponding population estimate needed to calculate a death rate.  Instead, we adjusted for 
Latino ethnicity at the county level, as in a previous similar analysis of CDC data.4  In a 
sensitivity analysis, we included Latino ethnicity as a stratification variable and excluded those 
deaths for whom ethnicity was unknown, and the results were quite similar.  Our preferred model 
used county-level data because it allowed us to use the richest set of economic indicators (county 
and year specific unemployment, median income, and poverty rate), and we felt that these 
potential confounders represented the greatest threat to the study’s internal validity.  County-
level analyses also allowed us to examine subgroups to assess the plausibility of the causal 
mechanism implied by our findings – we were able to look differentially at mortality declines by 
county household income and baseline rates of health insurance coverage.   
 
Definitions and Analyses of Deaths Amenable to Health Care 
We adapted previous work by Nolte & McKee (2003, 2008, 2011)12-14 defining mortality 
amenable to medical care (Appendix Table 1).  Our definition was more inclusive, and included 
all infectious and malignant causes of death (rather than a subset), congestive heart failure, and 
certain treatable arrhythmias.  We also removed several diagnoses less relevant to our study 
population (e.g., congenital cardiac malformations).  Our overall results were similar using both 
definitions: the post-reform relative mortality decline using the Nolte & McKee measure was -
5.5% (95% CI -8.9, -2.1, p=0.002), from a baseline of 99 per 100,000; the estimate using our 
 2 
revised criteria was -4.5% (95% CI -6.2, -2.7, p<0.001).  Non-amenable deaths using our 
definition did not significantly decline, with an estimate of -2.0% (95% CI -5.5, 1.5, p=0.26). 
 
Details of the Propensity Score Approach 
 The propensity score (PS) method used here is an adapted version of the approach used in 
non-randomized clinical trials of interventions such as a medical treatment, and is also analogous 
to the notion of a synthetic control group as outlined by Abadie and colleagues.5  We used a 
logistic regression model with multiple predictor variables to predict the outcome, which is the 
“treatment condition” – in this case, being a county in Massachusetts.  Massachusetts counties 
have an outcome = 1, and all other U.S. counties = 0.  The following variables were used to 
calculate the propensity scores: county-level information on race, ethnicity, age, sex, poverty 
rate, median household income, unemployment rate, uninsured rate prior in 2005, and annual 
baseline mortality rate from 2001-2006.  The analysis was conducted at the county level, 
weighted for the size of each county’s non-elderly adult population.  Fitted values were then 
obtained for each non-Massachusetts county, indicating a “propensity” (or more precisely, a 
similarity index) to Massachusetts. There was significant overlap: the PS range for 
Massachusetts counties was from 0.00001 to 0.72, and for non-Massachusetts control counties 
from essentially 0 (1.21x 10-27) to 0.99.  Then, using the propensity score, we identified the 
quartile of national counties that most closely resembled the overall population of 
Massachusetts’ 14 counties.  Table 2 shows that this approach achieved excellent balance, with 
no statistically significant differences in population characteristics between counties in the 
control group and those in Massachusetts. 
Our approach differed somewhat from more traditional PS approaches. Unlike a typical 
PS analysis of a patient-level clinical intervention (where each observation is equal sized), our 
unit of analysis for the mortality data is the county, where population size varies dramatically 
across each unit, and where our treatment condition (Massachusetts) has just 14 counties.  For 
these reasons, when we use a traditional PS method such as 2:1 nearest-neighbor matching,6 we 
end up with an underpowered sample (42 counties total), which is particularly limiting for 
potential subgroup analyses. We also considered a traditional PS regression adjustment strategy, 
using the full overlapping U.S. sample of counties, with direct adjustment for propensity scores 
in 10 deciles.7  This resulted in similar overall estimates as our preferred baseline model, though 
the differences in baseline trends in mortality for the U.S. as a whole versus Massachusetts 
(Appendix Table 3) [even after PS decile adjustment] suggest that this is a less convincing 
control group for a quasi-experimental approach than our primary specification.  However, it is 
reassuring that our main findings of relative mortality reductions in Massachusetts compared the 
control group were consistent across all three approaches (Appendix Table 4). 
  
Regression Models and Sensitivity Analyses 
Baseline GLM Model 
The baseline analysis used a generalized linear model (GLM) with negative binomial family and 
a log link, with population size as the exposure variable, and the following equation: 
 
Deathsijklt = β0 +βM MassReformlt + β1 Xijk +β2 County-Level Factorslt  
   + µ Yeart + Ω  Statel + εijklt      Equation (1) 
where i indexed age, j race, k sex, l county, and t year. Xijk was a vector of demographics (age 
group, race, and sex). County-Level Factors included county-year-specific poverty rate, median 
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income (in 2010 inflation-adjusted dollars), unemployment rate, and percentage of the 
population that is Latino. µ was a vector of year fixed effects, and Ω is a vector of state fixed 
effects. The coefficient of interest was βM, which captures the effect of living in Massachusetts 
after the year 2006. The regression used Huber-White robust standard errors clustered at the state 
level and was weighted for population size. 
 
Pre-Reform Trend Analyses (Sample limited to 2001-2006): 
To test for divergence in mortality trends prior to Massachusetts’ health reform, we used a 
generalized linear model (GLM) with negative binomial family and a log link, with population 
size as the exposure variable, and the following equation: 
 
Deathsijklt = β0 + β1 Xijk +β2 County-Level Factorslt + µ Time Trendt  
   + Φ Massachusettss*Time Trendt + Ω  Statel + εijklst   Equation (2) 
where µ was a linear time trend, and Φ was a Massachusetts-specific time trend, created by the 
interaction between the Time Trend and Massachusetts.  The quadratic time trend analyses 
simply replaced the linear time trend with time-trend squared, for both µ and Φ.  The other terms 
were defined as in Equation (1).  The results are presented in Appendix Table 3. 
 
Linear Model 
For comparability to prior similar analyses of insurance expansions and ease of interpretation of 
absolute changes,4 we also tested the following linear model using the mortality rate per 100,000 
as the outcome variable: 
 
Mortality Rateijklt = β0 +βM MassReformlt + β1 Xijk +β2 County-Level Factorslt  
   + µ Yeart + Ω  Countyl + εijklt      Equation (3) 
where Ω was a vector of county fixed effects (GLM models with county fixed effects did not 
converge due to the high number of counties, requiring the use of state fixed effects in Equation 
1; the linear model enabled us to adjust for time-invariant features at the county level).  The other 
terms were defined as in Equation (1).  The results are presented in Appendix Table 4. 
 
Elderly Adults as an Additional Control Group for Non-Elderly Adults in Massachusetts 
To test for changes in Massachusetts’ health reform for non-elderly (20-64) versus elderly adults 
(65 and over), we used a generalized linear model (GLM) with negative binomial family and a 
log link, with population size as the exposure variable, and the following equation: 
 
Deathsijklt = β0 + β Xijk +β1 Post-Reformt * Non-Elderlyi  
   +β2 Non-Elderlyi * Massachusettsl 
   +β3 Post-Reformt * Massachusettsl  
   +β4 Post-Reformt * Massachusettsl * Non-Elderlyi   
   +β5 County-Level Factorslt + µ Yeart + Ω  Statel + εijklst  Equation (4) 
where direct effects for Massachusetts and Post-Reform were captured by the state fixed effects 
and year fixed effects, respectively.  The direct effect of Non-Elderly was captured by the age 
dummy variables, which include a cut-point at 65 years.  β3 measures the relative change in 
mortality after reform among elderly adults in Massachusetts compared to elderly adults in the 
control states. The coefficient of interest was β4, which measured the relative change in mortality 
after health reform among non-elderly adults (20-64) in Massachusetts versus non-elderly adults 
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in the control states, net of the relative change in mortality among elderly adults (65+). The other 
terms were defined as in Equation (1).  This is also known as a “differences-in-differences-in-
differences” analysis.  The results are presented in Appendix Table 5. 
 
Subgroup Analysis 
To test for changes in Massachusetts’ health reform among subgroups of adults ages 20-64, we 
used a generalized linear model (GLM) with negative binomial family and a log link, with 
population size as the exposure variable, and the following equation: 
 
Deathsijklt = β0 + β Xijk +β1 Post-Reformt * SubgroupA 
   +β2  SubgroupA * Massachusettsl 
   +β3 Post-Reformt * Massachusettsl * SubgroupB 
   +β4 Post-Reformt * Massachusettsl * SubgroupA   
   +β5 County-Level Factorslt + µ Yeart + Ω  Statel + εijklst  Equation (5) 
where direct effects for Massachusetts and Post-Reform were captured by the state fixed effects 
and year fixed effects, respectively.  The direct effect of SubgroupA versus SubgroupB was  
included in the vector of covariates Xijk.  β3 measured the relative change in mortality after 
reform among SubgroupA in Massachusetts, compared to SubgroupA in control states. β4, 
measured the relative change in mortality after health reform among SubgroupB in Massachusetts 
versus SubgroupB in control states. The other terms were defined as in Equation (1). This 
approach allowed for direct post-estimation testing for between-group differences comparing β3 
and β4.  The results are presented in Appendix Table 5. 
 
Secondary Outcomes – Coverage, Access to Care, and Health Status: 
To test for changes in secondary outcomes using the CPS and BRFSS, we used a generalized 
linear model (GLM) with logit link, and Huber-White robust standard errors clustered at the state 
level, with the following equation: 
 
Pr(Outcomeist) = β0 +βM MassReformst + β1 Xit +µ Yeart + Ω  States +  π Yeart + εist   
          Equation (6) 
where i indexed individuals, s states, and t year. Xi was a vector of demographics (age, 
race/ethnicity, gender, family income as percentage of the federal poverty level, and employment 
status). µ was a vector of year fixed effects, and Ω was a vector of state fixed effects.  The 
coefficient of interest was βM, which captured the effect of living in Massachusetts after the year 
2006. Analyses of secondary outcomes (uninsured, cost-related barriers to care, usual source of 
care, checkup within the past year, and good/fair/poor self-reported health) all used Equation 6, 
with the only difference being the dependent variable.   
 
Estimating the Magnitude of Mortality Changes Related to Coverage Expansion 
 Appendix Table 7 presents calculations illustrating the implications of our results for 
individual-level changes in mortality due to the coverage expansion in Massachusetts.  This 
calculation used statistics from various sources: the total non-elderly adult population of 
Massachusetts (4.0 million) comes from the Kaiser Commission,8 and the baseline mortality rate 
in this population (283/100,000 = 0.283%) comes from Table 3.  We used the total of 6.8% new 
insurance enrollees estimated in Table 5.  Next we assumed a 30% individual mortality reduction 
of acquiring insurance, based on prior research.9,10  Then, we calculated what baseline mortality 
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rate was necessary among new insurance enrollees to have all of the above parameters yield a 
population-wide mortality reduction due to health reform equal to the result in Table 3 (2.9%).  
The overall conclusion is that the baseline mortality for new insurance enrollees must be 0.400% 
(400/100,000) to produce a population-wide mortality reduction from the state’s health reform 
that is consistent with our findings in Table 3. 
 
Sensitivity of Results to Omitted Confounders 
 To assess the sensitivity of our mortality results to the possibility of an omitted 
confounder, we followed the approach in Vanderweele et al. (2011).11  We posited the existence 
of an unmeasured confounder variable U with a prevalence 10% higher in the Massachusetts 
population after its health reform than before health reform, with no comparable change in U in 
the control group during this period.  For this confounder to explain the full absolute decline in 
estimated population mortality (-8.2 deaths per 100,000), the baseline mortality reduction for 
those with U = 1 compared to the general population (U=0) would need to be X, where 0.10 * -X 
= -8.2/100,000.   
 Solving this equation, X = 82 / 100,000.  This would amount to a 29% lower mortality 
rate for those with trait U than for the general Massachusetts population (82 / 283 = 29%). 
 Overall, we would need to posit a fairly high-prevalence of an unmeasured confounder 
that increased substantially after reform only in Massachusetts (+10 percent of the population) 
and that has a sizable impact on mortality, cutting it by nearly 30% compared to baseline.  Other 
than the major change in health insurance coverage during this period, it is difficult to identify 
what such a factor might have been that was not already included in our regression covariates 
and that did not also affect the elderly population. 
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Appendix Table 1: Definitions of Deaths Amenable to Health Care 
 
Condition(s) ICD-10 Codes Nolte & 
McKee 
Definition 
Authors’ 
Revised 
Definition 
Infectious & Parasitic Diseases (ALL) A00-B99  X 
 -Tuberculosis A16-19, B90 X X 
 -Other specific infections (diphtheria, tetanus, septicemia, 
poliomyelitis, whooping cough, measles) 
A35-A37, A40-41, 
A80, B05 
X X 
Neoplasms (ALL) C00-D48  X 
 -Malignant neoplasm of colon and rectum C18-C21 X X 
 -Malignant neoplasm of skin C44 X X 
 -Malignant neoplasm of breast C50 X X 
 -Malignant neoplasm of cervix or uterus C53-C55 X X 
 -Malignant neoplasm of testis C62 X X 
 -Hodgkin’s disease C81 X X 
 -Leukemia C91-C95 X X 
Disorders of thyroid gland E00-E07 X X 
Diabetes Mellitus E10-E14 X X 
Epilepsy G40-G41 X X 
Chronic rheumatic heart diseases I05-I09 X X 
Hypertensive diseases I10-I13, I15 X X 
Ischemic heart diseases I20-I25 X X 
Cardiomyopathy I42  X 
Atrial fibrillation and flutter I48  X 
Other cardiac arrhythmias I49  X 
Heart failure I50  X 
Cerebrovascular diseases I60-I69 X X 
All respiratory diseases J00-J98 X X 
Gastric and duodenal ulcers K25-K27 X X 
Gastrojejunal ulcers K28  X 
Diseases of appendix K35-K38 X X 
Hernia K40-K46 X X 
Diseases of gallbladder and biliary tract K80-K83 X X 
Acute pancreatitis K85  X 
Infections of the skin and subcutaneous tissue L00-L08  X 
Infectious arthropathies M00-M02  X 
Glomerular diseases N00-N07 X X 
Renal tubulo-interstitial diseases N10-N15  X 
Renal failure N17-N19 X X 
Unspecified contracted kidney, small kidney unknown cause N26-N27 X  
Hyperplasia of prostate N40 X  
Pregnancy, childbirth and the puerperium O00-O99 X X 
Congenital malformations originating in the perinatal period P00-P96 X  
Misadventures to patients during surgical and medical care Y60-Y69, Y83-Y84 X X 
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Appendix Table 2: Variables Used to Calculate Propensity Score 
 
Variable Odds Ratio 95% Confidence Interval P Value 
Ages 20-34 0.7959 0.5674 1.1163 0.186 
Ages 35-44 0.7819 0.4211 1.4519 0.44 
Ages 45-54 0.4389 0.1509 1.2769 0.131 
Ages 55-64 1.0000 -- -- reference 
Male 0.1595 0.0564 0.4507 0.001 
White 0.9879 0.9421 1.0360 0.62 
Black 0.8450 0.6931 1.0302 0.096 
Other Race 1.0000 -- -- reference 
Latino 0.9868 0.8929 1.0907 0.80 
Poverty Rate 0.9846 0.7848 1.2352 0.89 
Median Household Income 1.0000 0.9999 1.0001 0.65 
Unemployment Rate 1.4645 1.0873 1.9726 0.012 
Percent Uninsured 0.6345 0.5311 0.7580 <0.001 
Mortality Rate 2001 0.9934 0.9762 1.0108 0.45 
Mortality Rate 2002 1.0134 0.9999 1.0271 0.052 
Mortality Rate 2003 1.0100 0.9982 1.0220 0.097 
Mortality Rate 2004 1.0027 0.9930 1.0126 0.58 
Mortality Rate 2005 0.9841 0.9723 0.9960 0.009 
Mortality Rate 2006 0.9870 0.9670 1.0074 0.21 
Constant Term 2.23E+56 6.83E+38 7.31E+73 <0.001 
 
Notes: Based on population-weighted county-level logistic regression model using 2000-2006 data for adults ages 
20-64.  Mortality rates were expressed as deaths per 100,000 adults, and median household income in 2010 
inflation-adjusted dollars.  All other variables are expressed in percentage points (0-100). 
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Appendix Table 3: Tests of Pre-Reform Mortality Trends (per 100,000 Adults)  
in Massachusetts versus Control Group and Overall United States 
 
Comparison Group  
Relative to 
Massachusetts 
Differential 
Trend for 
Massachusetts 
vs. Control 
Group 
 
95% CI 
 
P value 
 
Differential 
Trend for 
Massachusetts 
vs. Other U.S. 
States 
95% CI P 
value  
 
Linear Time Trend, 
2001-2006 
-1.1 -2.4, 0.3 0.120 -1.9 -2.9, -0.8 <0.001 
Quadratic Time Trend, 
2001-2006 
-0.15 -0.34, 0.04 0.116 -0.27 -0.42, -0.12 <0.001 
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Appendix Table 4:  
Sensitivity Analyses of Estimates of Mortality Changes After Massachusetts’ Health 
Reform Among Adults 20-64 (2001-2010) 
 
MODEL 
Difference in 
Change, 
Massachusetts 
vs. Control 
Group 
95% CI P value 
    
Alternative Propensity Score (PS) Methods and Control 
Groups, All-Cause Mortality    
PS Regression Adjustment, in deciles, for all U.S. counties in 
areas of PS overlap with Massachusetts counties -2.5% -4.0, -1.0 0.001 
PS Matching (2:1 control:treatment)* -8.2% -12.6, -3.7 <0.001 
Baseline Model, excluding states with major Medicaid 
expansions† -3.3% -5.9, -0.7 0.012 
    
Baseline Model, with Alternative Standard Errors    
Unadjusted all-cause mortality, county-level clustering -4.2% -7.2, -1.2 0.006 
Adjusted all-cause mortality, county-level clustering -2.9% -5.5, -0.2 0.033 
Unadjusted health-care amenable mortality, county-level 
clustering -4.3% -7.8, -0.8 0.015 
Adjusted health-care amenable mortality, county-level clustering -4.5% -8.4, -0.5 0.028 
    
Linear Model, with Death Rate (per 100,000) as Outcome     
Unadjusted all-cause mortality -11.4 -22.3, -0.5 0.040 
Adjusted all-cause mortality -6.4 -10.8, -2.0 0.006 
Adjusted all-cause mortality, with county fixed effects* -9.3 -16.7, -1.9 0.014 
Unadjusted health-care amenable mortality -7.2 -12.3, -2.0 0.007 
Adjusted health-care amenable mortality -4.5 -8.3, -0.6 0.024 
Adjusted health-care amenable mortality, with county fixed 
effects* -7.5 -10.2, -4.7 <0.001 
    
State-Level Analyses§    
Unadjusted state-level mortality -4.1% -7.7, -0.5 0.025 
Adjusted state-level mortality -2.3% -5.1, 0.5 0.103 
Unadjusted state-level health-care amenable mortality -4.2% -6.8, -1.6 0.002 
Adjusted state-level health-care amenable mortality -4.5% -6.5, -2.6 <0.001 
    
Alternative Time Frame or Analytic Frame, All-Cause 
Mortality    
Include 2006 as the first post-reform year -3.5% -5.3, -1.8 <0.001 
Interrupted times series (pre-reform vs. post-reform trend)# -1.0% per year -1.8, -0.3 0.006 
Pre-reform versus post-reform pooled data (instead of yearly) -3.1% -5.2, -1.1 0.003 
Individual-level Latino ethnicity (omitting those with ethnicity 
unknown)¶ -3.0% -4.7, -1.4 <0.001 
 
Notes:  
* The baseline GLM model uses state level fixed effects; due to the number of counties in the baseline sample, the 
GLM models do not converge when using county fixed effects.  For the PS match model with a much smaller 
number of counties, and in the linear models, we are able to adjust for time-invariant county-level features using 
county fixed effects. 
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† Excluded states were Arizona, Illinois, Maine, and New York, which all implemented large Medicaid expansions 
to adults between 2001 and 2010.15 
§ Analysis conducted using the same control group but with mortality data aggregated to the state level (using state-
year-age-sex-race cells as the unit of analysis). 
# Replaces year fixed effects with a linear time trend, and replaces Massachusetts Post Reform binary variable with 
an interaction term between Massachusetts and Years Since Reform (i.e., year – 2006). 
¶ This model adjusts directly for Latino ethnicity, which requires omitting from the sample any deaths with 
“unknown” ethnicity, since the dataset has no corresponding population denominator for that group necessary to 
calculate a death rate.  This accounts for 0.3% of deaths among 20-64 years old nationally; omitting these deaths 
results in a reduction in the estimated national mortality rate of -1.2 deaths per 100,000. 
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Appendix Table 5: Analyses of Mortality Changes After Massachusetts’ Health Reform 
Among Adults 20-64, Using Elderly Adults as an Additional Control Group (2001-2010) 
 
OUTCOME and Variable Negative Binomial GLM 
Linear Regression of 
Ln(Death Rate), with County 
Fixed Effects# 
ALL CAUSE MORTALITY 
 Coefficient 95% CI 
P 
value Coefficient 95% CI 
P 
value 
Post-Reform*Massachusetts*Non-Elderly† -3.3 -6.6, 0.2 0.066 -3.9 -7.8, -0.1 0.046 
Post-Reform*Massachusetts§ 0.1 -2.5, 2.7 0.93 -0.3 -1.5, 0.9 0.61 
       
HEALTH-CARE AMENABLE 
MORTALITY 
 
Coefficient 95% CI P value Coefficient 95% CI 
P 
value 
Post-Reform*Massachusetts*Non-Elderly† -4.9 -7.1, -2.7 <0.001 -5.3 -7.9, -2.7 <0.001 
Post-Reform*Massachusetts§ 0.2 -2.4, 2.7 0.90 -1.1 -2.3, 0.2 0.096 
 
Notes:  
† Measures the differential change for non-elderly adults in Massachusetts relative to the control group, subtracting 
out the analogous changes among elderly adults. 
§ Measures the differential change for elderly adults in Massachusetts, relative to elderly adults in the control group. 
# The baseline GLM model uses state level fixed effects; due to the number of counties in the baseline sample, the 
GLM models do not converge when using county fixed effects.  For the linear model, we are able to adjust for time-
invariant county-level features using county fixed effects. 
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Appendix Table 6: Sensitivity Analyses of Access to Care and Health Status, After 
Massachusetts’ Health Reform  
 
 
 
OUTCOME 
Logit GLM, Robust Standard Errors,  
No Clustering 
Linear Probability Model, Robust 
Standard Errors with State 
Clustering 
Adjusted 
Odds Ratio, 
Post-
Massachusetts 
Health 
Reform 
95% CI P value 
Absolute 
Change in 
Predicted 
Probability 
(percentage 
points) 
Difference in 
Change, 
Massachusetts 
vs. Control 
Group 
(percentage 
points) 
95% CI P value 
Uninsured 0.43 0.37, 0.49 <0.001 -6.8 -6.8 -7.4, -6.3 <0.001 
Delayed Care 
Due to Cost in 
Past Year 
0.78 0.70, 0.87 <0.001 -2.0 -2.0 -3.3, -0.8 0.009 
No Usual Source 
of Care 0.84 
0.77, 
0.91 <0.001 -1.9 -1.7 -2.6, -0.8 0.006 
No Preventive 
Doctor’s Visit in 
Past Year 
0.82 0.74, 0.91 <0.001 -4.0 -3.8 -4.8, -2.8 <0.001 
Good/Fair/Poor 
Self-Reported 
Health (versus 
Excellent/Very 
Good) 
0.92 0.86, 0.98 0.008 -1.8 -1.8 -2.9, -0.8 0.007 
 
 
Notes: Analyses comparing these outcomes in Massachusetts to the propensity-score defined set of comparison 
counties (as in Tables 1-4) is not possible due to a lack of county-identifying information in these datasets. 
GLM = Generalized Linear Model 
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Appendix Table 7: Calculation of Simulated Mortality Benefit from Massachusetts’ Health 
Reform 
 
PRE-REFORM 
Group N Mortality Rate Deaths 
New Insurance Enrollees 272,000 0.400% 1,088 
All Other Adults 3,728,000 0.274% 10,232 
TOTAL 4,000,000 0.283% 11,320 
POST-REFORM 
Group N Mortality Rate Deaths 
New Insurance Enrollees 272,000 0.280% 762 
All Other Adults 3,728,000 0.274% 10,232 
TOTAL 4,000,000 0.275% 10,994 
 
Individual Mortality Reduction = (0.400% - 0.280%) / 0.400% = 30% 
Population-Wide Mortality Reduction = (11,320 - 10,994) / 11,320 = 2.9% 
Number Needed to Treat = 272,000 / (1088-762) = 830 
 
Note: 
See description of methods in Appendix. 
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Appendix Figure 1: Unadjusted Mortality Rates for  
Elderly Adults (65 and Older) from 2001-2010 
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